Why Shares of Si-Bone Jumped Tuesday

What happened

Shares of medical equipment company Si-Bone (NASDAQ:SIBN) were up more than 20% Tuesday morning before falling to a rise of just over 9% Tuesday afternoon after the healthcare company released first-quarter earnings. The stock is up more than 17% so far this year.

So what

Si-Bone makes and sells the iFuse Implant System to fuse the sacroiliac joint in the lower back and treat SI joint dysfunction. The company reported first-quarter earnings on Tuesday morning, and there were a lot of positives.

Si-Bone said it had revenue of $32.7 million in the quarter, up 46% year over year, including $30.5 million in U.S. revenue, up 50% from the same period last year. The company also narrowed its net losses year over year by 33% to $11.3 million. It also said it had $86 million in cash.

The company also increased its annual guidance for revenue, now saying it expects to bring in from $128 million to $131 million in revenue this year, representing an increase of 20% to 23%.

The reason for the stock's rise and then slight fall may have had to do with the fact the Nasdaq fell more than 1% in the afternoon.

Now what

As impressive as the numbers were, the most encouraging thing to consider for the long term is the company continues to expand its surgeon base. Si-Bone said it had 950 active surgeons performing iFuse operations at the end of the quarter, representing 40% growth over the same period last year. It's also the ninth straight quarter the company has seen a double-digit rise in its active surgeon base.

Si-Bone said it foresees the potential for 470,000 annual procedures in the U.S. using its systems, leading to a $3 billion-a-year revenue opportunity.

10 stocks we like better than Si-bone
When our analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*

They just revealed what they believe are the ten best stocks for investors to buy right now... and Si-bone wasn't one of them! That's right -- they think these 10 stocks are even better buys.

See the 10 stocks

*Stock Advisor returns as of May 1, 2023

Jim Halley has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.